Skip to main content
. 2014 Oct 30;5(4):908–915. doi: 10.18632/oncotarget.1484

Table 1. Disease status and biologic CLL disease characteristics.

Sample ID Disease Status Cytogenetics/FISH IgVh mutational status ZAP 70 CD38
PB 1 Relapsed Normal Mutated Negative Negative
PB 2 Untreated Normal Mutated Negative Negative
PB 3 Relapsed Unknown Unknown Unknown Unknown
PB 4 Relapsed 17p deletion
13q deletion
Unmutated Positive Positive
PB 5 Untreated 13q deletion Mutated Negative Negative
PB 6 Untreated 13q deletion Mutated Unknown Unknown
PB 7 Untreated 13q deletion Mutated Negative Negative
PB 8 Untreated 13q deletion Mutated Negative Negative
PB 9 Relapsed 13q deletion Unknown Unknown Unknown
PB 10 Relapsed 11q deletion
13q deletion
Unmutated Negative Positive
PB 11 Untreated 13q deletion Mutated Unknown Unknown
PB 12 Relapsed Trisomy 12 Unmutated Positive Negative
PB 13 Unknown Unknown Unknown Unknown Unknown
PB 14 Refractory Complex
17p deletion
Trisomy 12
Unmutated Positive Negative
BM 1 Refractory 13q deletion Unmutated Positive Positive
BM 2 Relapsed 13q deletion
Trisomy 12
Umutated Positive Negative
BM 3 Refractory 17p deletion
13q deletion
Unknown Negative Negative
BM 4 Untreated 13q deletion Unmutated Negative Negative